Pilot Study & AI

Research and developments at the intersection of artificial intelligence and healthcare.

Why it matters: AI is transforming how we diagnose, treat, and prevent disease. Staying informed helps clinicians and patients make better decisions.

10 research items

Get updates on this topic

Sort by Date Sort by Relevance

Safety Alert

From: 2026-03-16

ArXiv - AI in Healthcare (cs.AI + q-bio)Exploratory3 min read

Maternal health chatbot delivers vital info in low-resource areas

Key Takeaway:

A new chatbot shows promise in providing reliable maternal health information, especially in areas with limited healthcare access and low health literacy.

Researchers developed and tested a phone-based chatbot designed to support maternal healthcare in areas with low health literacy and limited medical access. The AI system was built to understand short, incomplete questions and handle queries that mix different languages. Despite receiving limited symptom details from users, the chatbot successfully provided accurate, trustworthy health information tailored to local contexts. Testing showed the chatbot can effectively guide mothers through pregnancy and postpartum questions, demonstrating its potential as a scalable tool to improve maternal and child health outcomes in underserved communities.

What this means for you

This chatbot could help provide maternal health information in the future, especially in areas with limited resources. It's still in early research, so continue following your doctor's advice for your healthcare needs.

NLP Clinical Pilot Study Telemedicine

Citation:

ArXiv, 2026. arXiv: 2603.13168 Read article →

Safety Alert

From: 2026-03-13

ArXiv - AI in Healthcare (cs.AI + q-bio)Exploratory3 min read

Simple phone chatbot delivers vital maternal health advice

Key Takeaway:

A new phone-based chatbot effectively delivers reliable maternal health information in low-resource settings, improving access to care for expectant mothers.

Scientists developed and tested a phone-based chatbot designed to support pregnant women in low-resource settings where medical access and health literacy are limited. The chatbot uses natural language processing to understand user text messages, which are often short, incomplete, or written in a mix of local languages. The system successfully provided accurate, trustworthy, and context-specific maternal health information to users. By delivering reliable guidance directly to mobile phones, this technology offers a scalable way to support expectant mothers and improve overall maternal health outcomes.

What this means for you

This chatbot shows promise for providing maternal health info in low-resource areas, but it's not available yet. Don't change your care based on this study. Always consult your doctor for guidance.

NLP Clinical Pilot Study Telemedicine

Citation:

ArXiv, 2026. arXiv: 2603.13168 Read article →

From: 2026-01-02

ArXiv - AI in Healthcare (cs.AI + q-bio)Exploratory3 min read

AI screens for depression in Nigerian Pidgin English

Key Takeaway:

Researchers are developing an AI tool to screen for depression in Nigerian Pidgin English, which could improve mental health access in Nigeria where resources are limited.

Researchers have fine-tuned a large language model to screen for depression in Nigerian Pidgin English, a language spoken by millions. Standard mental health screening tools are often culturally and linguistically inappropriate for populations in Nigeria, where clinical resources are scarce and mental health stigma is high. By training the AI on conversations in Nigerian Pidgin, researchers created a culturally relevant tool that can accurately screen for depression, making mental health support far more accessible.

What this means for you

This early research aims to improve depression screening in Nigerian Pidgin English. It's not available yet, so continue with your current care and consult your doctor for any concerns about your mental health.

NLP Clinical Pilot Study

Citation:

ArXiv, 2026. arXiv: 2601.00004 Read article →

Harnessing human-AI collaboration for an AI roadmap that moves beyond pilots

From: 2025-12-10

MIT Technology Review - AIExploratory3 min read

Most healthcare organizations struggle to move AI past pilot phase

Key Takeaway:

Most companies, including those in healthcare, struggle to move AI projects beyond testing stages despite significant investments, highlighting a need for better integration strategies.

Despite massive investments in artificial intelligence, a study reveals that three-quarters of enterprises remain stuck in the experimental pilot phase. In healthcare, where AI has the potential to revolutionize diagnostics and patient care, transitioning software from a small trial to daily clinical use is a major hurdle. By analyzing corporate AI strategies, researchers found that organizations struggle with the integration process, emphasizing that companies must focus on better human-AI collaboration and long-term roadmaps to actually deploy these tools.

What this means for you

This research is in early stages and not yet in healthcare settings. It may take years to see results. Continue with your current care plan and consult your doctor for personalized advice.

Clinical Decision Pilot Study

Citation:

MIT Technology Review - AI, 2025. Read article →

FDA announces TEMPO, a new pilot to tackle chronic disease with tech

From: 2025-12-09

Healthcare IT NewsExploratory3 min read

FDA launches TEMPO pilot for chronic disease tech

Key Takeaway:

FDA launches TEMPO pilot to improve chronic disease management by integrating digital health devices, aiming for safer and more effective patient care in the coming years.

The U.S. Food and Drug Administration has launched a new voluntary program called TEMPO to support the use of digital health technologies in managing chronic illnesses. Chronic diseases are leading causes of death worldwide and require constant, daily management. The TEMPO pilot program creates a collaborative framework where the FDA, technology developers, and healthcare providers can work together to safely implement digital tools like wearable sensors and smart monitors. The goal is to make it easier and safer for patients to use technology to manage their health from home.

What this means for you

"Exciting new FDA pilot explores tech to help manage chronic diseases. It's early, so don't change your care yet. Always consult your doctor for advice tailored to your health needs."

Pilot Study Cardiology Oncology

Citation:

Healthcare IT News, 2025. Read article →

From: 2025-12-09

MIT Technology Review - AIExploratory3 min read

Three-quarters of enterprise AI projects remain stuck in pilot phase

Key Takeaway:

Despite heavy investment, most healthcare organizations are still testing AI, which could significantly enhance diagnostics and treatment planning once fully implemented.

An MIT study looking at how organizations adopt artificial intelligence found that three-quarters of enterprises are still stuck in the experimental pilot phase. Despite historic levels of funding and high interest in AI's potential to improve medical diagnostics, patient management, and treatment planning, very few organizations have successfully transitioned these tools into daily, full-scale operations. This stagnation represents a major bottleneck in healthcare, meaning the promised benefits of clinical AI are still out of reach for the vast majority of patients.

What this means for you

This AI research is still in early stages and not yet in clinics. It may take years to be available. Continue following your doctor's advice for your current healthcare needs.

Clinical Decision Pilot Study

Citation:

MIT Technology Review - AI, 2025. Read article →

From: 2025-12-08

Healthcare IT NewsExploratory3 min read

FDA launches TEMPO pilot to accelerate chronic disease tech

Key Takeaway:

The FDA's new TEMPO pilot aims to improve outcomes for chronic disease patients by safely integrating digital health devices into care practices.

The FDA has announced a new voluntary pilot program called TEMPO, aimed at bringing digital health devices to chronic disease patients faster. The initiative encourages developers and manufacturers to submit their technologies for a streamlined review process. By focusing on safety and efficacy, the FDA hopes to integrate advanced digital health tools directly into clinical practice, helping patients manage long-term conditions more effectively.

What this means for you

The FDA's TEMPO pilot aims to improve chronic disease care with digital devices. It's early research, so don't change your treatment yet. Always consult your doctor about your health needs and current care plan.

Pilot Study Telemedicine

Citation:

Healthcare IT News, 2025. Read article →

From: 2025-12-08

MIT Technology Review - AIExploratory3 min read

Most enterprise AI initiatives remain stuck in pilot phase

Key Takeaway:

Despite high investment in AI, 75% of companies are still testing AI tools and struggling to implement them fully, highlighting the need for better integration strategies.

An analysis by MIT Technology Review shows that while corporate investment in AI is at an all-time high, roughly 75% of enterprises cannot transition their AI projects from pilot to full production. By reviewing AI initiatives across multiple industries, researchers identified common barriers to deployment, such as scalability and workflow integration, which closely mirror the challenges healthcare organizations face when trying to adopt clinical AI.

What this means for you

This AI research is still in early stages and not yet used in healthcare. It may take years to become available. Please continue following your doctor's current advice for your care.

Clinical Decision Pilot Study

Citation:

MIT Technology Review - AI, 2025. Read article →

From: 2025-12-05

Healthcare IT NewsExploratory3 min read

FDA launches TEMPO pilot to advance chronic disease tech

Key Takeaway:

The FDA's new TEMPO pilot aims to improve chronic disease management by promoting safe access to digital health devices, addressing the rising prevalence of these conditions.

The Food and Drug Administration has launched a new voluntary program called TEMPO to help patients manage chronic illnesses using digital health devices. Chronic diseases are incredibly common and require constant tracking. The TEMPO pilot is designed to bring the FDA and technology developers together to speed up the review of digital tools, like smart monitors and health apps. By ensuring these devices are both safe and effective, the program aims to get helpful technology into the hands of patients faster, making daily disease management easier.

What this means for you

The FDA's TEMPO pilot aims to improve chronic disease care with digital devices. It's early research, so don't change your current treatment. Always consult your doctor for advice tailored to your needs.

Pilot Study Cardiology Oncology

Citation:

Healthcare IT News, 2025. Read article →

From: 2025-12-05

MIT Technology Review - AIExploratory3 min read

Most healthcare AI remains stuck in the pilot phase

Key Takeaway:

AI's full-scale use in healthcare is still in early stages, with most projects stuck in trials despite significant investments.

An investigation into corporate AI adoption reveals that three-quarters of organizations are still stuck in the experimental trial phase. This trend is highly visible in healthcare, where AI shows massive potential to improve diagnostics and patient care but struggles to scale up. Researchers analyzed data from various organizations and interviewed industry leaders to find out why these projects stall. They found that moving from a small, controlled pilot project to a widespread, daily tool requires deep human-AI collaboration and better planning, which most institutions currently lack.

What this means for you

This AI research is promising but still in early stages. It may take years before it's used in healthcare. Continue following your doctor's advice and don't change your care based on this study.

Clinical Decision Pilot Study Telemedicine

Citation:

MIT Technology Review - AI, 2025. Read article →

Exploring Pilot Study? Learn how to interpret medical AI research →